TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours
出版年份 2017 全文链接
标题
TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours
作者
关键词
TRIM8, Drug resistance, N-MYC, p53, miR-17 family
出版物
Molecular Cancer
Volume 16, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-03-21
DOI
10.1186/s12943-017-0634-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Sorafenib Decreases Tumor Exposure to an Anti-carcinoembryonic Antigen Monoclonal Antibody in a Mouse Model of Colorectal Cancer
- (2016) Veena A. Thomas et al. AAPS Journal
- Last line therapy with sorafenib in colorectal cancer: A retrospective analysis
- (2016) Ksenia Martchenko et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Selective use of sorafenib in the treatment of thyroid cancer
- (2016) Fabián Pitoia et al. Drug Design Development and Therapy
- TRIM8 downregulation in glioma affects cell proliferation and it is associated with patients survival
- (2015) Lucia Micale et al. BMC CANCER
- Clinical observation of liver cancer patients treated with axitinib and cabozantinib after failed sorafenib treatment: a case report and literature review
- (2015) Bin Zhang et al. CANCER BIOLOGY & THERAPY
- MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer
- (2015) Lin Zheng et al. Journal of Translational Medicine
- Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma
- (2015) Jian-Jun Gao WORLD JOURNAL OF GASTROENTEROLOGY
- Predicting effective microRNA target sites in mammalian mRNAs
- (2015) Vikram Agarwal et al. eLife
- miR-17/20 sensitization of breast cancer cells to chemotherapy-induced apoptosis requires Akt1
- (2015) Zuoren Yu et al. Oncotarget
- TRIM8 anti-proliferative action against chemo-resistant renal cell carcinoma
- (2015) Mariano Francesco Caratozzolo et al. Oncotarget
- MicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression
- (2015) Lekun Fang et al. Oncotarget
- Mechanisms of Acquired Resistance to Tyrosine Kinase Inhibitors in Clear - Cell Renal Cell Carcinoma (ccRCC)
- (2014) Zofia Bielecka et al. Current Signal Transduction Therapy
- miR-106b-25/miR-17-92clusters: Polycistrons with oncogenic roles in hepatocellular carcinoma
- (2014) Weiqi Tan WORLD JOURNAL OF GASTROENTEROLOGY
- Imperfect centered miRNA binding sites are common and can mediate repression of target mRNAs
- (2014) Hilary C Martin et al. GENOME BIOLOGY
- The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease
- (2013) E Mogilyansky et al. CELL DEATH AND DIFFERENTIATION
- Integrated molecular analysis of clear-cell renal cell carcinoma
- (2013) Yusuke Sato et al. NATURE GENETICS
- TRIM8 modulates p53 activity to dictate cell cycle arrest
- (2012) Mariano Francesco Caratozzolo et al. CELL CYCLE
- miR-17-5p Inhibitor Enhances Chemosensitivity to Gemcitabine Via Upregulating Bim Expression in Pancreatic Cancer Cells
- (2012) Hai-jiao Yan et al. DIGESTIVE DISEASES AND SCIENCES
- The miR-17∼92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes
- (2012) R Bomben et al. LEUKEMIA
- TRIM8 regulates Nanog via Hsp90β-mediated nuclear translocation of STAT3 in embryonic stem cells
- (2011) Fumihiko Okumura et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- TRIM family: Pleiotropy and diversification through homomultimer and heteromultimer formation
- (2011) Luisa M. Napolitano et al. IUBMB LIFE
- Nutlin-3 enhances sorafenib efficacy in renal cell carcinoma
- (2011) Rit Vatsyayan et al. MOLECULAR CARCINOGENESIS
- miR-34 miRNAs provide a barrier for somatic cell reprogramming
- (2011) Yong Jin Choi et al. NATURE CELL BIOLOGY
- Tripartite motif 8 (TRIM8) modulates TNF - and IL-1 -triggered NF- B activation by targeting TAK1 for K63-linked polyubiquitination
- (2011) Q. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Novel treatment of medullary thyroid cancer
- (2011) Masahiro Sugawara et al. Current Opinion in Endocrinology Diabetes and Obesity
- Genomic and proteomic approaches to renal cell carcinoma
- (2010) Miriam Zacchia et al. JOURNAL OF NEPHROLOGY
- p73 and p63 Sustain Cellular Growth by Transcriptional Activation of Cell Cycle Progression Genes
- (2009) K. Lefkimmiatis et al. CANCER RESEARCH
- The miR-17-92 Cluster is Over Expressed in and Has an Oncogenic Effect on Renal Cell Carcinoma
- (2009) Tsz-fung F. Chow et al. JOURNAL OF UROLOGY
- A survey of therapy for advanced renal cell carcinoma
- (2009) Michele Basso et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells
- (2008) Sai-Wen Tang et al. CANCER LETTERS
- MicroRNAs in the miR-106b Family Regulate p21/CDKN1A and Promote Cell Cycle Progression
- (2008) I. Ivanovska et al. MOLECULAR AND CELLULAR BIOLOGY
- The MYCN oncogene is a direct target of miR-34a
- (2008) J S Wei et al. ONCOGENE
- Antagomir-17-5p Abolishes the Growth of Therapy-Resistant Neuroblastoma through p21 and BIM
- (2008) Laura Fontana et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now